Anti-Inflammatory & Antimicrobial Cream Franchise in Ahmedabad

Betaprol G Cream Supplier in Mumbai

Inflammatory Skin Cream Distributor in Delhi

Betamethasone Gentamicin Cream Manufacturer in Bangalore

Dermatology & Skin Care Cream Stockist in Hyderabad
Anti-Inflammatory Cream Exporter in Chandigarh

Home/Products /betamethasone-0-1-w-w-gentamicin-0-1-w-w-cream

Betaprol G Cream

Composition : Betamethasone (0.1% w/w) + Gentamicin (0.1% w/w) Cream

Dosage Form : Cream

Packaging Type : Tube

Packaging : 15gm

Price : ₹0/-

Betaprol G Cream contains Betamethasone 0.1% w/w, a potent corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties, and Gentamicin 0.1% w/w, a broad-spectrum aminoglycoside antibiotic. This combination addresses inflammation and secondary bacterial infection simultaneously, enhancing therapeutic outcomes.

Clinically, this cream is indicated for inflamed dermatoses with bacterial superinfection, eczema with secondary infection, allergic dermatitis, and other inflammatory skin conditions complicated by bacterial colonization. The dual action provides rapid relief of redness, swelling, and discomfort.

The cream formulation ensures optimal skin penetration, uniform application, and sustained local effect, making it suitable for dermatology clinics, hospitals, outpatient dermatology care, and specialty pharmacies. Topical administration allows for convenient use and improved patient adherence.

Betaprol G Cream helps in reducing inflammation, controlling bacterial infection, relieving itching, and promoting faster healing of affected skin areas. With its proven safety and clinical efficacy under supervised use, it remains a trusted anti-inflammatory and antimicrobial topical therapy for dermatological care.

Read More

About the Product

Betaprol G Cream contains Betamethasone 0.1% w/w, a potent corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties, and Gentamicin 0.1% w/w, a broad-spectrum aminoglycoside antibiotic. This combination addresses inflammation and secondary bacterial infection simultaneously, enhancing therapeutic outcomes.

Clinically, this cream is indicated for inflamed dermatoses with bacterial superinfection, eczema with secondary infection, allergic dermatitis, and other inflammatory skin conditions complicated by bacterial colonization. The dual action provides rapid relief of redness, swelling, and discomfort.

The cream formulation ensures optimal skin penetration, uniform application, and sustained local effect, making it suitable for dermatology clinics, hospitals, outpatient dermatology care, and specialty pharmacies. Topical administration allows for convenient use and improved patient adherence.

Betaprol G Cream helps in reducing inflammation, controlling bacterial infection, relieving itching, and promoting faster healing of affected skin areas. With its proven safety and clinical efficacy under supervised use, it remains a trusted anti-inflammatory and antimicrobial topical therapy for dermatological care.

Common side effects may include mild burning, itching, or irritation at the site of application. Prolonged use may rarely lead to skin thinning, stretch marks, local infections, or systemic corticosteroid effects. Allergic reactions are uncommon.

Betaprol G Cream is indicated for the management of inflammatory skin conditions complicated by bacterial infections, such as eczema, dermatitis, psoriasis with secondary infection, and other localized bacterial skin infections, as prescribed by a physician.

For external use only. Apply a thin layer to the affected area as directed by a healthcare professional. Avoid contact with eyes, mouth, and mucous membranes. Do not use for prolonged periods without medical supervision. Pregnant and lactating women should consult a doctor before use.

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation